Related references
Note: Only part of the references are listed.A review of systematic reviews of the cost-effectiveness of hormone therapy, chemotherapy, and targeted therapy for breast cancer
Vakaramoko Diaby et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Effects of Pharmacogenetics on the Pharmacokinetics and Pharmacodynamics of Tamoxifen
Aurelia H. M. de Vries Schultink et al.
CLINICAL PHARMACOKINETICS (2015)
Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trials
David M. Hyman et al.
DRUG DISCOVERY TODAY (2015)
Optimizing Endocrine Therapy for Breast Cancer
Amelia B. Zelnak et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2015)
Precision medicine for metastatic breast cancer-limitations and solutions
Monica Arnedos et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
The history and future of targeting cyclin-dependent kinases in cancer therapy
Uzma Asghar et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Palbociclib in Hormone-Receptor-Positive Advanced Breast Cancer
Nicholas C. Turner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Modeling the energetic cost of cancer as a result of altered energy metabolism: implications for cachexia
Douglas E. Friesen et al.
THEORETICAL BIOLOGY AND MEDICAL MODELLING (2015)
Somatic Cell Fusions Reveal Extensive Heterogeneity in Basal-like Breast Cancer
Ying Su et al.
CELL REPORTS (2015)
The Proteomic Landscape of Triple-Negative Breast Cancer
Robert T. Lawrence et al.
CELL REPORTS (2015)
Personalized medicine and economic evaluation in oncology: all theory and no practice?
Livio Garattini et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2015)
The Sweden Cancerome Analysis Network - Breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine
Lao H. Saal et al.
GENOME MEDICINE (2015)
A Computational Strategy to Select Optimized Protein Targets for Drug Development toward the Control of Cancer Diseases
Nicolas Carels et al.
PLOS ONE (2015)
Inside single cells: quantitative analysis with advanced optics and nanomaterials
Yi Cui et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2015)
Cancer Metabolism and Drug Resistance
Mahbuba Rahman et al.
METABOLITES (2015)
Delivering precision medicine in oncology today and in future-the promise and challenges of personalised cancer medicine: a position paper by the European Society for Medical Oncology (ESMO)
F. Ciardiello et al.
ANNALS OF ONCOLOGY (2014)
The AURORA initiative for metastatic breast cancer
D. Zardavas et al.
BRITISH JOURNAL OF CANCER (2014)
The pharmacological point of view of resistance to therapy in tumors
Giovanna Damia et al.
CANCER TREATMENT REVIEWS (2014)
A Proteome-Scale Map of the Human Interactome Network
Thomas Rolland et al.
CELL (2014)
Outcomes by Tumor Subtype and Treatment Pattern in Women With Small, Node-Negative Breast Cancer: A Multi-Institutional Study
Ines Vaz-Luis et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Picking the Point of Inhibition: A Comparative Review of PI3K/AKT/mTOR Pathway Inhibitors
Rodrigo Dienstmann et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Clonal evolution in breast cancer revealed by single nucleus genome sequencing
Yong Wang et al.
NATURE (2014)
Mass-spectrometry-based draft of the human proteome
Mathias Wilhelm et al.
NATURE (2014)
Detection of cancer biomarkers in serum using a hybrid mechanical and optoplasmonic nanosensor
P. M. Kosaka et al.
NATURE NANOTECHNOLOGY (2014)
Mathematical modeling of multi-drugs therapy: a challenge for determining the optimal combinations of antiviral drugs
Yoshiki Koizumi et al.
THEORETICAL BIOLOGY AND MEDICAL MODELLING (2014)
Integrating genomics into clinical oncology: Ethical and social challenges from proponents of personalized medicine
Michelle L. McGowan et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
Essential elements of personalized medicine
Wylie Burke et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
Hedgehog signaling pathway as a new therapeutic target in pancreatic cancer
Hideya Onishi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Ultradeep Human Phosphoproteome Reveals a Distinct Regulatory Nature of Tyr and Ser/Thr-Based Signaling
Kirti Sharma et al.
CELL REPORTS (2014)
Personalized Medicine and Human Genetic Diversity
Yi-Fan Lu et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)
Immune approaches to the treatment of breast cancer, around the corner?
Carmen Criscitiello et al.
BREAST CANCER RESEARCH (2014)
Profiling of normal and malignant breast tissue show CD44high/CD24low phenotype as a predominant stem/progenitor marker when used in combination with Ep-CAM/CD49f markers
Hazem Ghebeh et al.
BMC CANCER (2013)
Understanding breast cancer stem cell heterogeneity: time to move on to a new research paradigm
Ferdinando Mannello
BMC MEDICINE (2013)
Whole-exome sequencing reveals recurrent somatic mutation networks in cancer
Xiaoping Liu et al.
CANCER LETTERS (2013)
Regulation of mTORC1 and its impact on gene expression at a glance
Mathieu Laplante et al.
JOURNAL OF CELL SCIENCE (2013)
The causes and consequences of genetic heterogeneity in cancer evolution
Rebecca A. Burrell et al.
NATURE (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers
Steven A. Roberts et al.
NATURE GENETICS (2013)
Emerging targeted agents in metastatic breast cancer
Dimitrios Zardavas et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
Wanjuan Yang et al.
NUCLEIC ACIDS RESEARCH (2013)
Boolean Network Model for Cancer Pathways: Predicting Carcinogenesis and Targeted Therapy Outcomes
Herman F. Fumia et al.
PLOS ONE (2013)
Mammosphere Formation in Breast Carcinoma Cell Lines Depends upon Expression of E-cadherin
Juan Manuel Iglesias et al.
PLOS ONE (2013)
Personalized medicine in oncology: where have we come from and where are we going?
Fabrice Andre et al.
PHARMACOGENOMICS (2013)
A patient-specific therapeutic approach for tumour cell population extinction and drug toxicity reduction using control systems-based dose-profile design
Suhela Kapoor et al.
THEORETICAL BIOLOGY AND MEDICAL MODELLING (2013)
The Faces of Personalized Medicine: A Framework for Understanding Its Meaning and Scope
W. Ken Redekop et al.
VALUE IN HEALTH (2013)
Fibroblast Growth Factor Receptor Inhibitors as a Cancer Treatment: From a Biologic Rationale to Medical Perspectives
Maria Vittoria Dieci et al.
CANCER DISCOVERY (2013)
Cellular network entropy as the energy potential in Waddington's differentiation landscape
Christopher R. S. Banerji et al.
SCIENTIFIC REPORTS (2013)
Intra-tumor heterogeneity: lessons from microbial evolution and clinical implications
Elza C. de Bruin et al.
GENOME MEDICINE (2013)
IGF-1R as an anti-cancer target-trials and tribulations
Helen X. Chen et al.
CHINESE JOURNAL OF CANCER (2013)
WNT signalling pathways as therapeutic targets in cancer
Jamie N. Anastas et al.
NATURE REVIEWS CANCER (2013)
Detection of circulating tumor cells in blood of metastatic breast cancer patients using a combination of cytokeratin and EpCAM antibodies
Ulrike Weissenstein et al.
BMC CANCER (2012)
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Douglas Hanahan et al.
CANCER CELL (2012)
The Origin and Evolution of Mutations in Acute Myeloid Leukemia
John S. Welch et al.
CELL (2012)
The Life History of 21 Breast Cancers
Serena Nik-Zainal et al.
CELL (2012)
Towards a statistical mechanics of cell fate decisions
Jordi Garcia-Ojalvo et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2012)
Insulin-like Growth Factor-1 Receptor (IGF-1R) Kinase Inhibitors in Cancer Therapy: Advances and Perspectives
Mengzhu Xue et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy
Libero Santarpia et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
Redirected Antitumor Activity of Primary Human Lymphocytes Transduced With a Fully Human Anti-mesothelin Chimeric Receptor
Evripidis Lanitis et al.
MOLECULAR THERAPY (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Bagging Statistical Network Inference from Large-Scale Gene Expression Data
Ricardo de Matos Simoes et al.
PLOS ONE (2012)
Subtype and pathway specific responses to anticancer compounds in breast cancer
Laura M. Heiser et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Molecular signaling network complexity is correlated with cancer patient survivability
Dylan Breitkreutz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Next generation sequencing in epigenetics: Insights and challenges
Emma Meaburn et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2012)
FGF Receptor Inhibitors: Role in Cancer Therapy
Gennaro Daniele et al.
CURRENT ONCOLOGY REPORTS (2012)
Differential network entropy reveals cancer system hallmarks
James West et al.
SCIENTIFIC REPORTS (2012)
Gene regulatory network inference: evaluation and application to ovarian cancer allows the prioritization of drug targets
Piyush B. Madhamshettiwar et al.
GENOME MEDICINE (2012)
Chapter 7: Pharmacogenomics
Konrad J. Karczewski et al.
PLOS COMPUTATIONAL BIOLOGY (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Heterogeneity of breast cancer: etiology and clinical relevance
Vanessa Almendro et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2011)
Increasing Tamoxifen Dose in Breast Cancer Patients Based on CYP2D6 Genotypes and Endoxifen Levels: Effect on Active Metabolite Isomers and the Antiestrogenic Activity Score
M. F. Barginear et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Characterization of the single-cell transcriptional landscape by highly multiplex RNA-seq
Saiful Islam et al.
GENOME RESEARCH (2011)
Recent insights into the effect of natural and environmental estrogens on mammary development and carcinogenesis
Vassiliki Pelekanou et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2011)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Initial genome sequencing and analysis of multiple myeloma
Michael A. Chapman et al.
NATURE (2011)
An overview of the c-MET signaling pathway
Shawna Leslie Organ et al.
Therapeutic Advances in Medical Oncology (2011)
Targeting hypoxia in cancer therapy
William R. Wilson et al.
NATURE REVIEWS CANCER (2011)
DNA Damage Repair and Telomere Length in Normal Breast, Preneoplastic Lesions, and Invasive Cancer
Christophe M. Raynaud et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2010)
Increased entropy of signal transduction in the cancer metastasis phenotype
Andrew E. Teschendorff et al.
BMC SYSTEMS BIOLOGY (2010)
AACR Centennial Series: The Biology of Cancer Metastasis: Historical Perspective
James E. Talmadge et al.
CANCER RESEARCH (2010)
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kai Kessenbrock et al.
CELL (2010)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
Regulation of death receptor signaling by the ubiquitin system
I. E. Wertz et al.
CELL DEATH AND DIFFERENTIATION (2010)
Tumor metabolism of lactate: the influence and therapeutic potential for MCT and CD147 regulation
Kelly M. Kennedy et al.
FUTURE ONCOLOGY (2010)
Targeting Chromosomal Instability and Tumour Heterogeneity in HER2-Positive Breast Cancer
Rebecca A. Burrell et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2010)
Epithelial-Mesenchymal Transition in Cancer: Parallels Between Normal Development and Tumor Progression
Douglas S. Micalizzi et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2010)
The DNA Damage Response: Making It Safe to Play with Knives
Alberto Ciccia et al.
MOLECULAR CELL (2010)
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Mark E. Davis et al.
NATURE (2010)
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
A. Singh et al.
ONCOGENE (2010)
Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes
Joseph H. Taube et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Induction of Lymphoidlike Stroma and Immune Escape by Tumors That Express the Chemokine CCL21
Jacqueline D. Shields et al.
SCIENCE (2010)
Heterogeneity of the Tumor Vasculature
Janice A. Nagy et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2010)
TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression
Li Yang et al.
TRENDS IN IMMUNOLOGY (2010)
Wnt signal transduction pathways
Yuko Komiya et al.
Organogenesis (2010)
Breast Cancer Biomarker Discovery in the Functional Genomic Age: A Systematic Review of 42 Gene Expression Signatures
M. C. Abba et al.
BIOMARKER INSIGHTS (2010)
SENESCENCE Senescence in tumours: evidence from mice and humans
Manuel Collado et al.
NATURE REVIEWS CANCER (2010)
Vascular Endothelial Growth Factor
Napoleone Ferrara
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Micrometastatic disease and metastatic outgrowth: clinical issues and experimental approaches
Patricia M. McGowan et al.
FUTURE ONCOLOGY (2009)
Tumor suppressors and cell metabolism: a recipe for cancer growth
Russell G. Jones et al.
GENES & DEVELOPMENT (2009)
Recommendations from the EGAPP Working Group: can tumor gene expression in patients with breast cancer?
Alfred O. Berg et al.
GENETICS IN MEDICINE (2009)
Cancer genome sequencing: a review
Elaine R. Mardis et al.
HUMAN MOLECULAR GENETICS (2009)
Cancer stem cells: mirage or reality?
Piyush B. Gupta et al.
NATURE MEDICINE (2009)
Literature-curated protein interaction datasets
Michael E. Cusick et al.
NATURE METHODS (2009)
Pyruvate into lactate and back: From the Warburg effect to symbiotic energy fuel exchange in cancer cells
Olivier Feron
RADIOTHERAPY AND ONCOLOGY (2009)
Involvement of Members of the Cadherin Superfamily in Cancer
Geert Berx et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2009)
Metastatic cancer cell
Marina Bacac et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2008)
Necroptosis: A Specialized Pathway of Programmed Necrosis
Lorenzo Galluzzi et al.
CELL (2008)
The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation
Ralph J. DeBerardinis et al.
CELL METABOLISM (2008)
Immune-mediated dormancy: an equilibrium with cancer
Michele W. L. Teng et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Transforming Growth Factor-β Signaling-Deficient Fibroblasts Enhance Hepatocyte Growth Factor Signaling in Mammary Carcinoma Cells to Promote Scattering and Invasion
Nikki Cheng et al.
MOLECULAR CANCER RESEARCH (2008)
The ground state of embryonic stem cell self-renewal
Qi-Long Ying et al.
NATURE (2008)
Mapping and quantifying mammalian transcriptomes by RNA-Seq
Ali Mortazavi et al.
NATURE METHODS (2008)
Cancer growth:: Predictions of a realistic model
S. A. Menchon et al.
PHYSICAL REVIEW E (2008)
Cysteine cathepsin proteases as pharmacological targets in cancer
Carmela Palermo et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
Cellular mechanisms of tumour suppression by the retinoblastoma gene
Deborah L. Burkhart et al.
NATURE REVIEWS CANCER (2008)
Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis
Ralph J. DeBerardinis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
How to improve reliability and efficiency of research about molecular markers: roles of phases, guidelines, and study design
David F. Ransohoff
JOURNAL OF CLINICAL EPIDEMIOLOGY (2007)
Influence of cytochrome P450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic and clinical aspects
Magnus Ingelman-Sundberg et al.
PHARMACOLOGY & THERAPEUTICS (2007)
Modelling the role of angiogenesis and vasculogenesis in solid tumour growth
I. J. Stamper et al.
BULLETIN OF MATHEMATICAL BIOLOGY (2007)
Epithelial-mesenchymal and mesenchymal - Epithelial transitions in carcinoma progression
Honor Hugo et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
What can we learn from the population incidence of cancer? Armitage and Doll revisited
Chris Hornsby et al.
LANCET ONCOLOGY (2007)
Heterogeneous expression of Wnt/β-catenin target genes within colorectal cancer
Falk Hlubek et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Breast cancer vaccines - Promise for the future or pipe dream?
Elizabeth A. Mittenclorf et al.
CANCER (2007)
Contact-dependent inhibition of EGFR signaling by Nf2/Merlin
Marcello Curto et al.
JOURNAL OF CELL BIOLOGY (2007)
The human disease network
Kwang-Il Goh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Cancer immunoediting from immune surveillance to immune escape
Ryungsa Kim et al.
IMMUNOLOGY (2007)
Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors
Jeffrey B. Wyckoff et al.
CANCER RESEARCH (2007)
Chemical combination effects predict connectivity in biological systems
Joseph Lehar et al.
MOLECULAR SYSTEMS BIOLOGY (2007)
New insights on the anticancer properties of dietary polyphenols
P. Fresco et al.
MEDICINAL RESEARCH REVIEWS (2006)
A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes
O. A. Kent et al.
ONCOGENE (2006)
Alveolar and lactogenic differentiation
Cathrin Brisken et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2006)
microRNAs exhibit high frequency genomic alterations in human cancer
Lin Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Molecular targets of dietary agents for prevention and therapy of cancer
BB Aggarwal et al.
BIOCHEMICAL PHARMACOLOGY (2006)
An integrated computational/experimental model of tumor invasion
HB Frieboes et al.
CANCER RESEARCH (2006)
A multiscale model for avascular tumor growth
Y Jiang et al.
BIOPHYSICAL JOURNAL (2005)
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
The advantages and disadvantages of being polyploid
L Comai
NATURE REVIEWS GENETICS (2005)
Merlin/NF-2 mediates contact inhibition of growth by suppressing recruitment of Rac to the plasma membrane
T Okada et al.
JOURNAL OF CELL BIOLOGY (2005)
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer
EH Romond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Modulation of DNA end joining by nuclear proteins
L Liang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Telomeres and human disease: Ageing, cancer and beyond
MA Blasco
NATURE REVIEWS GENETICS (2005)
Personalised medicine for cancer: from drug development into clinical practice
KK Jain
EXPERT OPINION ON PHARMACOTHERAPY (2005)
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Endoxifen (4-hydroxy-N-desmethyl-tamoxifen) has anti-estrogenic effects in breast cancer cells with potency similar to 4-hydroxy-tamoxifen
YC Lim et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2005)
Robustness and network evolution - an entropic principle
L Demetrius et al.
PHYSICA A-STATISTICAL MECHANICS AND ITS APPLICATIONS (2005)
Pharmacological characterization of 4-hydroxy-N-desmethyl tamoxifen, a novel active metabolite of tamoxifen
MD Johnson et al.
BREAST CANCER RESEARCH AND TREATMENT (2004)
Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates
A Gabizon et al.
ADVANCED DRUG DELIVERY REVIEWS (2004)
Network motifs in integrated cellular networks of transcription-regulation and protein-protein interaction
E Yeger-Lotem et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Network biology:: Understanding the cell's functional organization
AL Barabási et al.
NATURE REVIEWS GENETICS (2004)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: Prominent roles for CYP3A and CYP2D6
Z Desta et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Stromal fibroblasts in cancer initiation and progression
NA Bhowmick et al.
NATURE (2004)
Current status of delivery systems to improve target efficacy of oligonucleotides
Y Shoji et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
The Wnt signaling pathway in development and disease
CY Logan et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY (2004)
Preferential attachment in the protein network evolution
E Eisenberg et al.
PHYSICAL REVIEW LETTERS (2003)
The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones
P Workman
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2003)
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells
G Dontu et al.
GENES & DEVELOPMENT (2003)
Subnetwork hierarchies of biochemical pathways
P Holme et al.
BIOINFORMATICS (2003)
Minimally modified phosphodiester antisense oligodeoxyribonucleotide directed against the multidrug resistance gene mdr1
I Brigui et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Scale-free networks are ultrasmall
R Cohen et al.
PHYSICAL REVIEW LETTERS (2003)
A comparison of normalization methods for high density oligonucleotide array data based on variance and bias
BM Bolstad et al.
BIOINFORMATICS (2003)
Network motifs: Simple building blocks of complex networks
R Milo et al.
SCIENCE (2002)
Hierarchical organization of modularity in metabolic networks
E Ravasz et al.
SCIENCE (2002)
Specificity and stability in topology of protein networks
S Maslov et al.
SCIENCE (2002)
Design and application of a cytokine-receptor-based interaction trap
S Eyckerman et al.
NATURE CELL BIOLOGY (2001)
Lethality and centrality in protein networks
H Jeong et al.
NATURE (2001)
Revisiting retinoblastoma protein phosphorylation during the mammalian cell cycle
S Cooper et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2001)
Error and attack tolerance of complex networks
R Albert et al.
NATURE (2000)
An atlas of mouse mammary gland development
MM Richert et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2000)
Share Paper
